News Results
There are 326,269 News Results
Mar 1, 2019
PLANO, Texas, March 1, 2019 /PRNewswire/ -- Toyota Motor North America (TMNA) today reported February 2019 sales of 172,748 vehicles, a decrease of 5.2 percent from February 2018 on a...
Mar 4, 2019
AMSTERDAM, March 4, 2019 /PRNewswire/ -- -- FERACCRU(® )(Ferric Maltol) met primary endpoint against Ferinject® (IV Ferric Carboxymaltose (FCM)) and shows clear benefits to Iron Deficiency Anaemia (IDA) patients with...
Mar 4, 2019
PLYMOUTH MEETING, Pa., March 4, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the initiation and opening of sites to enroll the second portion of the company's Phase...
Mar 4, 2019
PALM BEACH, Florida, March 4, 2019 /PRNewswire/ -- Medical technology is an area where the U.S. companies are at the forefront. In fact, according to recent industry publication the: "U.S....
Mar 4, 2019
PALM BEACH, Florida, March 4, 2019 /PRNewswire/ -- While many private sector industries in the U.S. vigorously denounce the government's intrusion, control and over-regulation on many matters, the largest complaint...
Mar 6, 2019
STOCKHOLM, March 6, 2019 /PRNewswire/ --
Mar 6, 2019
WOODCLIFF LAKE, N.J., March 6, 2019 /PRNewswire/ -- Eisai announced today that new data from a real world observational study of the use of eribulin mesylate injection (marketed as HALAVEN(®))...
Mar 7, 2019
SILVER SPRING, Md., March 7, 2019 /PRNewswire/ -- We're at a critical point for the future of biosimilars in the U.S. Millions of American patients stand to benefit from increased...
Mar 11, 2019
TOKYO and STAMFORD, Conn., March 11, 2019 /PRNewswire/ -- Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma...
Mar 12, 2019
DUBLIN, March 12, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first patient in a Phase 2b/3 study of TD-1473...